D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ALXO holding history
Alx Oncology Holdings Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALXO overviewAll 13F holders of ALXOFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −75,900−100.0% | Sold out | Holders |
| Q1 2025 | 75,900 | $47.3K | <0.1% | −179,978−70.3% | Reduced | Holders |
| Q4 2024 | 255,878 | $427.3K | <0.1% | −34,518−11.9% | Reduced | Holders |
| Q3 2024 | 290,396 | $528.5K | <0.1% | +271,456+1,433.2% | Added | Holders |
| Q2 2024 | 18,940 | $114.2K | <0.1% | +18,940 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −50,178−100.0% | Sold out | Holders |
| Q4 2023 | 50,178 | $747.1K | <0.1% | +4,496+9.8% | Added | Holders |
| Q3 2023 | 45,682 | $219.3K | <0.1% | −2,525−5.2% | Reduced | Holders |
| Q2 2023 | 48,207 | $362.0K | <0.1% | +7,132+17.4% | Added | Holders |
| Q1 2023 | 41,075 | $185.7K | <0.1% | +15,152+58.5% | Added | Holders |
| Q4 2022 | 25,923 | $292.2K | <0.1% | +700+2.8% | Added | Holders |
| Q3 2022 | 25,223 | $241.0K | <0.1% | −9,163−26.6% | Reduced | Holders |
| Q2 2022 | 34,386 | $278.0K | <0.1% | +34,386 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −7,710−100.0% | Sold out | Holders |
| Q3 2021 | 7,710 | $569.0K | <0.1% | −38,109−83.2% | Reduced | Holders |
| Q2 2021 | 45,819 | $2.50M | <0.1% | −6,439−12.3% | Reduced | Holders |
| Q1 2021 | 52,258 | $3.85M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.